Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium.
about
Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial culturesTriggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte deathMEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivoPhase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemiaVasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsIdentification of SPLUNC1's ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airways.Inflammatory targets of therapy in sickle cell disease.The paradox of the neutrophil's role in tissue injury.Biomarkers in sickle cell disease.The effect and side effect of hydroxyurea therapy on patients with β-thalassemia: a systematic review to December 2012.Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.Potential of Three Ethnomedicinal Plants as Antisickling Agents.The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.
P2860
Q24338348-17914D6A-3758-4C46-A195-0E04D3839883Q26852497-EE03FE34-B563-45FE-B019-76BA71EA19ADQ27335195-57ECAF78-D82D-4983-BB08-6599301CA009Q28540243-F45B1157-DEC8-420B-9911-701F7AEECFC4Q34992760-17C2437B-304F-4703-A1EE-618E0E70660AQ36252318-C65FADE6-D571-45D7-9402-BF7C81D10D63Q36385224-DEFFA73E-AFE1-4998-8EC7-7265B6417DC9Q37811628-9F928E77-97E0-4215-87BC-A75CD69F709CQ37961814-25FC07F6-F26C-4297-A6EC-D8F25F45698FQ38229328-F4B4E50C-B4EB-43B8-BE5C-7CC16C7084C4Q47113073-9606A4F0-57A9-4152-81A7-0AB0BD0C72FBQ47245130-453DB2EA-97BF-45C6-BDB3-BB78D5C95448Q51065755-9A421F5F-48DE-424F-9E53-CACFD91578E2
P2860
Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@en
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@nl
type
label
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@en
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@nl
prefLabel
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@en
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@nl
P2093
P2860
P1476
Hydroxyurea attenuates activat ...... ulmonary vascular endothelium.
@en
P2093
B Surendra Baliga
Boniface Obiako
Johnson Haynes
Raymond B Hester
Troy Stevens
P2860
P304
P356
10.1152/AJPHEART.01068.2007
P577
2007-11-09T00:00:00Z